Bausch Health Companies Stock News

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bausch (BHC) reported earnings 30 days ago. What's next for the stock?

Bausch Health (BHC) closed the most recent trading day at $24.05, moving +1.69% from the previous trading session.

CNBC's Jim Cramer spoke with Bausch Health CEO Joe Papa in Tuesday's edition of "Mad Money."

As the Fed is expected to lift interest rates today, inflation shows no sign of slowing in any commodity outside of oil.

As the Fed is expected to lift interest rates today, inflation shows no sign of slowing in any commodity outside of oil.

"Mad Money" host Jim Cramer rings the lightning round bell, which means he''s giving his answers to callers'' stock questions at rapid speed.

In the latest trading session, Bausch Health (BHC) closed at $21.97, marking a -1.08% move from the previous day.

Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at 2022 Barclays Global Healthcare Conference (Transcript)

Dallas, March 11, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global inflammatory bowel disease treatment market is expected to grow from USD 18.47 billion in 2020 to USD 28.96 billion by 2030, at a CAGR of 4.6% during the forecast period 2021-2030. Inflammatory bowel disease (IBD) is a term for illnesses involving chronic inflammation of the digestive tract. Some common symptoms of IBD are: abdominal pain, weight loss, persistent diarrhea, rectal bleeding and fatigue. Ulcerative colitis and Crohn''s disease are the two most common kinds of IBD. The colon or large intestine are the only parts of the body affected by ulcerative colitis. On the other hand, Crohn''s disease can affect any portion of the gastrointestinal tract, from the mouth to the anus. The last part of the small intestine or the colon, or both, are the most usually affected areas. Anti-inflammatory drugs are frequently used as the first line of treatment against inflammatory bowel disease.

Bausch Health (BHC) closed at $22.56 in the latest trading session, marking a -0.84% move from the prior day.

Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at Cowen 42nd Annual Healthcare Conference (Transcript)

With another rough day in the markets unfolding, we want to put a small amount of money to work in quality companies.